Aspartyl-tRNA synthetase is a class II tRNA synthetase and occurs in a multisynthetase complex in mammalian cells. Human Asp-tRNA synthetase contains a short 32-residue amino-terminal extension that can control the release of charged tRNA and its direct transfer to elongation factor 1␣; however, whether the extension binds to tRNA directly or interacts with the synthetase active site is not known. Full-length human AspRS, but not amino-terminal 32 residue-deleted, fully active AspRS, was found to bind to noncognate tRNA fMet in the presence of Mg 2؉ . Synthetic amino-terminal peptides bound similarly to tRNA fMet , whereas little or no binding of polynucleotides, poly(dA-dT), or polyphosphate to the peptides was found. The apparent binding constants to tRNA by the peptide increased with increasing concentrations of Mg 2؉ , suggesting Mg 2؉ mediates the binding as a new mode of RNA⅐peptide interactions. The binding of tRNA fMet to amino-terminal peptides was also observed using fluorescence-labeled tRNAs and circular dichroism. These results suggest that a small peptide can bind to tRNA selectively and that evolution of class II tRNA synthetases may involve structural changes of amino-terminal extensions for enhanced selective binding of tRNA.Aminoacyl-tRNA synthetases catalyze the covalent attachments of amino acids to cognate tRNAs in the first step of protein biosynthesis. Extensive studies of the structure and function of this family of enzymes have provided excellent understanding of fundamental principles of RNA-protein interactions and structures of synthetases. Almost all synthetases contain a core catalytic domain carrying out adenylation of an amino acid and an anti-codon binding domain essential for aminoacylation of cognate tRNA. The core catalytic domains in class I synthetases resemble dinucleotide binding folds and reside in the amino termini, whereas a seven-stranded antiparallel sheet with three ␣-helices characterizes active sites in class II synthetases and locates in the carboxyl termini of synthetases.Beyond the basic amino-and carboxyl-terminal catalytic domains, eukaryotic and mammalian synthetases (1-3) have evolved idiosyncratic extensions dispensable for aminoacylation of tRNA. Additionally, extensive association of synthetases occurs in high eukaryotic organisms; thus, 9 of the 20 synthetases associate as a multienzyme complex, ProRS and GluRS form a fused GluProRS (4, 5), and ValRS associates with the EF1H as a separate complex (6, 7). The function of the extensions in synthetases has attracted more attention recently. Controlled proteolysis or hydrophobic interaction chromatography dissociates several synthetases from the synthetase complex without significantly affecting enzymatic activities (8, 9); thus, the extensions in mammalian synthetases likely play pivotal roles in the structural organization of the synthetase complex. Extensions in synthetases can be involved in RNA binding (10, 11) or function as cytokines (12)(13)(14). It appears that extensions in synthetases are multifun...